303 related articles for article (PubMed ID: 1358042)
21. Logarithmic relationship of the CD4 count to survival in patients with human immunodeficiency virus infection.
Nightingale SD; Jockusch JD; Haslund I; Cal SX; Peterson DM; Loss SD
Arch Intern Med; 1993 Jun; 153(11):1313-8. PubMed ID: 8099477
[TBL] [Abstract][Full Text] [Related]
22. The effects on survival of early treatment of human immunodeficiency virus infection.
Graham NM; Zeger SL; Park LP; Vermund SH; Detels R; Rinaldo CR; Phair JP
N Engl J Med; 1992 Apr; 326(16):1037-42. PubMed ID: 1347907
[TBL] [Abstract][Full Text] [Related]
23. [The prognostic markers of survival and progression in HIV-1 infection. A study of CD4+ lymphocytes, antigen p24 and viral load during 3 years in a cohort of 251 patients].
Rubio Caballero M; Nogués Biau A; Falguera Sacrest M; Puig Ganau T; Lecha N; Rubio Rivas C
An Med Interna; 2000 Oct; 17(10):533-7. PubMed ID: 11109648
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months.
Perriëns JH; St Louis ME; Mukadi YB; Brown C; Prignot J; Pouthier F; Portaels F; Willame JC; Mandala JK; Kaboto M
N Engl J Med; 1995 Mar; 332(12):779-84. PubMed ID: 7862181
[TBL] [Abstract][Full Text] [Related]
25. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection.
Selwyn PA; Hartel D; Lewis VA; Schoenbaum EE; Vermund SH; Klein RS; Walker AT; Friedland GH
N Engl J Med; 1989 Mar; 320(9):545-50. PubMed ID: 2915665
[TBL] [Abstract][Full Text] [Related]
26. A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS.
Gordin FM; Matts JP; Miller C; Brown LS; Hafner R; John SL; Klein M; Vaughn A; Besch CL; Perez G; Szabo S; El-Sadr W
N Engl J Med; 1997 Jul; 337(5):315-20. PubMed ID: 9233868
[TBL] [Abstract][Full Text] [Related]
27. Higher mortality in HIV-2/HTLV-1 co-infected patients with pulmonary tuberculosis in Guinea-Bissau, West Africa, compared to HIV-2-positive HTLV-1-negative patients.
Norrgren H; Bamba S; Da Silva ZJ; Koivula T; Andersson S
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e142-7. PubMed ID: 20395161
[TBL] [Abstract][Full Text] [Related]
28. Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire.
Mukadi Y; Perriëns JH; St Louis ME; Brown C; Prignot J; Willame JC; Pouthier F; Kaboto M; Ryder RW; Portaels F
Lancet; 1993 Jul; 342(8864):143-6. PubMed ID: 8101257
[TBL] [Abstract][Full Text] [Related]
29. Accelerated course of human immunodeficiency virus infection after tuberculosis.
Whalen C; Horsburgh CR; Hom D; Lahart C; Simberkoff M; Ellner J
Am J Respir Crit Care Med; 1995 Jan; 151(1):129-35. PubMed ID: 7812542
[TBL] [Abstract][Full Text] [Related]
30. [A comparative analysis of the clinical and laboratory characteristics in disseminated penicilliosis marneffei in patients with and without human immunodeficiency virus infection].
Zhang JQ; Yang ML; Zhong XN; He ZY; Liu GN; Deng JM; Li MH
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Oct; 31(10):740-6. PubMed ID: 19080599
[TBL] [Abstract][Full Text] [Related]
31. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy.
Selwyn PA; Sckell BM; Alcabes P; Friedland GH; Klein RS; Schoenbaum EE
JAMA; 1992 Jul 22-29; 268(4):504-9. PubMed ID: 1619742
[TBL] [Abstract][Full Text] [Related]
32. Should pulmonary tuberculosis be an AIDS-defining diagnosis in patients infected with HIV?
Perronne C; Ghoubontni A; Leport C; Salmon-Céron D; Bricaire F; Vildé JL
Tuber Lung Dis; 1992 Feb; 73(1):39-44. PubMed ID: 1525376
[TBL] [Abstract][Full Text] [Related]
33. Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda.
Whalen CC; Nsubuga P; Okwera A; Johnson JL; Hom DL; Michael NL; Mugerwa RD; Ellner JJ
AIDS; 2000 Jun; 14(9):1219-28. PubMed ID: 10894287
[TBL] [Abstract][Full Text] [Related]
34. Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya. Analysis of early (6-month) mortality.
Nunn P; Brindle R; Carpenter L; Odhiambo J; Wasunna K; Newnham R; Githui W; Gathua S; Omwega M; McAdam K
Am Rev Respir Dis; 1992 Oct; 146(4):849-54. PubMed ID: 1416409
[TBL] [Abstract][Full Text] [Related]
35. Six-month supervised intermittent tuberculosis therapy in Haitian patients with and without HIV infection.
Chaisson RE; Clermont HC; Holt EA; Cantave M; Johnson MP; Atkinson J; Davis H; Boulos R; Quinn TC; Halsey NA
Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1034-8. PubMed ID: 8887603
[TBL] [Abstract][Full Text] [Related]
36. [The prognostic value of plasma triglycerides in human immunodeficiency virus infection].
Rovira E; Belda A; Martínez MD; Gonzalvo F; Pascual JM; Redón J
Rev Clin Esp; 1995 Jul; 195(7):455-8. PubMed ID: 7667519
[TBL] [Abstract][Full Text] [Related]
37. Tuberculous meningitis in HIV-infected patients in Brazil: clinical and laboratory characteristics and factors associated with mortality.
Croda MG; Vidal JE; Hernández AV; Dal Molin T; Gualberto FA; de Oliveira AC
Int J Infect Dis; 2010 Jul; 14(7):e586-91. PubMed ID: 20005759
[TBL] [Abstract][Full Text] [Related]
38. HIV prevalence, immunosuppression, and drug resistance in patients with tuberculosis in an area endemic for AIDS.
Shafer RW; Chirgwin KD; Glatt AE; Dahdouh MA; Landesman SH; Suster B
AIDS; 1991 Apr; 5(4):399-405. PubMed ID: 1676282
[TBL] [Abstract][Full Text] [Related]
39. Factors associated with an increased case-fatality rate in HIV-infected and non-infected South African gold miners with pulmonary tuberculosis.
Churchyard GJ; Kleinschmidt I; Corbett EL; Murray J; Smit J; De Cock KM
Int J Tuberc Lung Dis; 2000 Aug; 4(8):705-12. PubMed ID: 10949321
[TBL] [Abstract][Full Text] [Related]
40. HIV/AIDS among Palestinians: detection, clinical presentation, prognosis and HIV testing patterns, 1994-2010.
Rosenthal A; Elinav H; Ramlawi A; Shasha D; Olshtain-Pops K; Korem M; Arafeh I; Maayan S
Int J Infect Dis; 2011 Jun; 15(6):e377-81. PubMed ID: 21466966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
